Valsartan

Valsartan Campaign Details

Prices listed are the current retail value and may be higher or lower based on availability, size of budget, demand, volatility and additional filters.

  • Valsartan lead
    Call for pricing
  • Valsartan signed
    Call for pricing

Valsartan Criteria

  • Took any of the following blood pressure medications after Jan 1, 2014
    • valsartan (Diovan & Prexxartan)
    • aliskiren + valsartan (Valturna)
    • amlodipine + valsartan (Exforge)
    • nebivolol + valsartan (Byvalson)
    • sacubitril + valsartan (Entresto)
    • losartan (Cozaar)
    • irbesartan (Avapro)
  • Diagnosed with one of the following cancers while on the medication
    • Liver cancer
    • Gastric cancer
    • Esophageal cancer
    • Stomach cancer
    • Colon cancer
    • Colorectal cancer
    • Kidney cancer
    • Intestinal cancer
    • Anal cancer
    • Pancreatic cancer
    • Gallbladder cancer
    • Other digestive tract cancer
  • Not diagnosed with cancer prior to Valsartan use
  • No legal representation

Valsartan Background Information

Medications

Diovan, Valturna, Exforge, Byvalson, Entresto, Cozaar, Avapro

Manufacturers

Teva Pharmaceuticals, Torent Pharmaceuticals, Prinston Pharmaceuticals, Solco Healthcare, Major Pharmaceuticals, Actavis, A-s Medication Solutions, AvKARE, NuCare Pharmaceuticals, Bryant Ranch Repack, Northwind Pharmaceuticals, RemedyRepack, Camber Pharmaceuticals

Issues

Valsartan and other generic angiotensin II receptor blockers (ARB’s), which are used to treat hypertension (which effects 1 in 3 Americans) have been found to be contaminated with an impurity called NNitrosodimehtylamine (NDMA). NDMA is a well-known carcinogen and exposure to such leads to significant risk of liver cancer, liver failure, stomach cancer, colorectal cancer, bowel cancer, and kidney cancer.

FDA Warning

July 13, 2018 FDA issues its largest Class 1 Recall ever. More that 2,000,000 Americans received a recall letter due to the possible NDMA contamination of their generic valsartan ARB. There have been numerous follow-on recalls by the FDA as well as similar associated announcements by the WHO, Health Canada, European Medical Association (EMA), Hong Kong Dept. of Health

MDL

No current MDL. Plaintiff firms has filed for centralization in the District of New Jersey, requesting US District Court Judge, Freda Wolfson, to preside over the matter if the JPML grants consolidation. Judge Wolfson is currently overseeing MDL #2738, a consolidation of talcum powder claimants.

CONTACT US

We welcome you to contact Mass Torts USA for more information
about our products and services.